person

Oliver H.

Country
Germany
Department
Klinik für Frauenheilkunde und Geburtshilfe

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
263
Sites with multiple studies

Has run more than one trial at 263 of 533 partner sites.

Specializations

Early Breast Cancer Focus

Specialized in investigating treatments for hormone receptor-positive (HR+) and HER2-negative early breast cancer, with particular emphasis on adjuvant therapeutic approaches. Conducts research exploring novel endocrine therapy combinations for improved patient outcomes.

  • HR+/HER2- Early Stage Disease
  • Adjuvant Treatment Strategies
  • Endocrine Therapy Optimization

Actively investigates biomarker-driven treatment approaches in early-stage breast cancer settings.

Advanced Treatment Modalities

Focuses on developing innovative approaches for HER2-positive breast cancer treatment, including evaluation of targeted therapies and antibody-drug conjugates. Investigates neoadjuvant treatment strategies for high-risk breast cancer patients.

  • HER2+ Targeted Therapies
  • Antibody-Drug Conjugates
  • Neoadjuvant Treatment Approaches

Explores chemotherapy-free treatment strategies and precision medicine approaches.

Innovative Therapeutic Approaches

Investigates triple-negative breast cancer treatments through immunotherapy combinations and explores molecular patterns of treatment efficacy in advanced disease settings. Studies novel therapeutic agents for hormone receptor-positive advanced breast cancer.

  • Immunotherapy Applications
  • Molecular Response Patterns
  • Advanced Disease Management

Focuses on developing personalized treatment strategies based on molecular profiling.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.